Home › Business › Pharmaceuticals News
December 18, 2013
Amy Schulman, who appeared headed toward a key leadership role running one of three Pfizer Inc. business divisions being launched in January, is leaving the pharmaceutical giant by what the company describes as “mutual agreement.”
December 17, 2013
Bioscience innovators and supporters gathered Monday at the Garde Arts Center in New London to hear how a cutting-edge chemical engineering company incubated in Groton took explosive new ideas and turned them into a fast-growing business.
December 17, 2013
Joseph S. Zakrzewski, successful in guiding Amarin Corp. plc toward regulatory approval of its heart drug Vascepa but stymied in attempts to bring the remedy to a wider market, has resigned as chief executive of the biotech.
John F. Thero,...
December 11, 2013
Pfizer Inc. has won a $7.7 million contract from the Pentagon to help speed vaccines to the public in the event of a health emergency related to bioterrorism.
The three-year contract, as reported in the industry blog FierceVaccines, was...
December 10, 2013
Pfizer Inc. lost an appeal to the U.S. Supreme Court Monday over the off-label marketing of the epilepsy remedy Neurontin.
The decision, made without comment, meant that Pfizer likely will have to pay a $142 million award to Kaiser...
December 8, 2013
Uncovering drugs that successfully combat neurodegenerative diseases such as Alzheimer's has been like finding a needle in a hayloft.
Industry statistics show that only 7 percent of experimental drugs to treat neurodegenerative disorders,...
December 3, 2013
Amarin Corp. plc said Monday that several company officials will be eligible for payments up to $250,000 if the U.S. Food and Drug Administration approves its request for expanded use of heart drug Vascepa.
Amarin's chief executive, Joseph...
November 30, 2013
The English drug firm GlaxoSmithKline has joined other major pharmaceutical companies, including Pfizer Inc., by announcing its intent to focus new attention on innovation centers including Cambridge, Mass.
November 28, 2013
Kathrin Jansen, senior vice president of vaccine research and early development at Pfizer Inc., has been named one of the top women in biotech for 2013.
FierceBiotech's list of 13 top scientific minds, available at www.fiercebiotech.com,...
November 23, 2013
Amarin Corp. plc said Friday that the U.S. Food and Drug Administration has denied the company's appeal of an agency decision that sent the company's stock into a tailspin.
According to a regulatory...
November 20, 2013
Pfizer has a new name in the Twitterverse.
According to the pharmaceutical site PMlive.com, the New York-based drug giant can finally use @pfizer as its official Twitter handle. Previously, the company had been forced to adopt @pfizer_news,...
November 18, 2013
The city and the Renaissance City Development Association are continuing to explore the construction of a parking garage in the Fort Trumbull neighborhood to accommodate the parking needs of Electric Boat and future development on the peninsula.
November 16, 2013
John Beauregard, executive director of the Franklin-based agency that operates the region's four CTWorks career centers, said Friday that the Norwich-New London labor market likely bottomed out in May and has been on its way up ever since, adding...
November 10, 2013
Ledyard - What do grape crops and missile stops have in common?
Yes, it turns out these complicated mathematical formulas that very few...
November 8, 2013
Two weeks after Amarin Corp. plc saw its stock price take a tumble, a class action lawsuit has been filed against the company and its chief executive.
Steven Sklar of New York City is the lead litigant...
November 7, 2013
Bruce Freundlich, a former Pfizer Inc. vice president, has been named senior vice president of medical affairs for Antares Pharma.
Freundlich was a Pfizer executive in charge of inflammation and...
November 7, 2013
Amarin Corp. plc plans a live webcast at 4:30 p.m. today to discuss third-quarter financial results.
The Irish-based biotech company, which has its research headquarters in Groton, is expected to post...
October 31, 2013
The Food and Drug Administration has rescinded an agreement with Amarin Corp. plc that investors once saw as virtually assuring the biotech firm's lead drug, Vascepa, would win regulatory approval for a wider market.
The Irish drug company,...
October 30, 2013
The growing use of two relatively new oncology products in Pfizer Inc.'s pipeline helped the drug giant turn in a respectable third-quarter performance, according to a financial report released Tuesday.
October 24, 2013
Pfizer Inc. has announced the closure of an Australian manufacturing plant in 2015.
The New York-based company told 140 workers Thursday in Sydney that their jobs were being phased out as part of a global realignment, according to a report...
October 23, 2013
Responding to a significant regulatory setback for its key heart medication, Amarin Corp. plc said Tuesday that the company plans to cut its worldwide staff in half.
Although Amarin is nominally an Irish company and has its official U.S.